Wesfarmers share price closes higher — here’s what’s driving WES.AX ahead of results
Wesfarmers shares rose 0.8% to A$83.33 Tuesday, outperforming the S&P/ASX 200’s 0.66% drop. Investors are focused on the Feb. 19 half-year results after news that Infinity Pharmacy Group, a major Priceline franchisee, entered administration owing Wesfarmers about A$110 million. Concerns remain over potential losses in the health division.